Quality-adjusted life years in macular oedema due to age-related macular degeneration, diabetes and central retinal vein occlusion: the impact of anti-VEGF agents in a tertiary centre in Greece
Article in International Ophthalmology (April 2022)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
Quality-Adjusted Life Years in Macular Edema: The Benefit of Anti-VEGF Agents in a Tertiary Center in Greece
Preprint in Research Square (August 2021)
Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Article in Clinical Ophthalmology (October 2020)